DanCann Pharma A/S Logo

DanCann Pharma A/S

DANCAN | SPGR

Overview

Corporate Details

ISIN(s):
DK0061410487
LEI:
549300KLXQ6IC2YUUB58
Country:
Denmark
Address:
Rugvænget 5, 6823 Ansager
Sector:
Health Care
Industry:
Pharmaceuticals

Description

DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Laboratorios Farmaceuticos Rovi S.A. Logo Laboratorios Farmaceuticos Rovi S.A. Spain ROVI
Lavipharm S.A. Logo Lavipharm S.A. Greece LAVI
Magle Chemoswed Holding AB Logo Magle Chemoswed Holding AB Sweden MAGLE
Malin Corporation Plc Logo Malin Corporation Plc Ireland MLC
Medika d.d. Logo Medika d.d. Croatia MDKA
Meditrina Cyprus Plc Logo Meditrina Cyprus Plc Cyprus MEDTR
Medivir Logo Medivir Sweden MVIR
Mithra Pharmaceuticals S.A. Logo Mithra Pharmaceuticals S.A. Belgium MITRA
Moberg Pharma Logo Moberg Pharma Sweden MOB
Molecular Partners AG Logo Molecular Partners AG Switzerland MOLN